Heparin-induced thrombocytopenia: Diagnosis, natural history, and treatment options

Postgraduate Medicine

Volumn 103, Issue 2, 1998, Pages 169-178

  Kelton, John G ^a   Warkentin, Theodore E ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANCROD; ARGATROBAN; DANAPAROID; DEXTRAN; DIPYRIDAMOLE; HEPARIN; HIRUDIN; LOW MOLECULAR WEIGHT HEPARIN; PROSTACYCLIN DERIVATIVE; WARFARIN;

AMPUTATION; BLEEDING; DOSE RESPONSE; HEART INFARCTION; HEPARIN INDUCED THROMBOCYTOPENIA; HEPARINIZATION; HUMAN; IMMUNITY; REVIEW; STROKE; THROMBOCYTE ACTIVATION; THROMBOCYTOPENIA; THROMBOSIS;

EID: 0031929767     PISSN: 00325481     EISSN: None     Source Type: Journal    
DOI: 10.3810/pgm.1998.02.357     Document Type: Review

References (23)

1. Warkentin TE, Kelton JG. Interaction of heparin with platelets including heparin-induced thrombocytopenia. In: Bounameaux H, ed. Low-molecular-weight heparins in prophylaxis and therapy of thromboembolic diseases. New York: Dekker, 1994:75-127
2. Warkentin TE, Kelton JG. Heparin-induced thrombocytopenia. Prog Hemost Thromb 1991;10:1-34
3. Kelton JG. Heparin-induced thrombocytopenia. Haemostasis 1986;16(2):173-86
4. Warkentin TE, Levine MN, Hirsh J, et al. Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin. N Engl J Med 1995;332(20):1330-5
5. Laster JL, Nichols WK, Silver D. Thrombocytopenia associated with heparin-coated catheters in patients with heparin-associated antiplatelet antibodies. Arch Intern Med 1989;149(10):2285-7
6. Powers PJ, Kelton JG, Carter CJ. Studies on the frequency of heparin-associated thrombocytopenia. Thromb Res 1984;33:439-43
7. Laster J, Cikrit D, Walker N, et al. The heparin-induced thrombocytopenia syndrome: an update. Surgery 1987;102(4): 763-70
8. Boshkov LK, Warkentin TE, Hayward CP, et al. Heparin-induced thrombocytopenia and thrombosis: clinical and laboratory studies. Br J Haematol 1993;84(2): 322-8
9. Kelton JG, Sheridan D, Brain H, et al. Clinical usefulness of testing for a heparin-dependent platelet-aggregating factor in patients with suspected heparin-associated thrombocytopenia. J Lab Clin Med 1984; 103(4):606-12
10. Sheridan D, Carter C, Kelton JG. A diagnostic test for heparin-induced thrombocytopenia. Blood 1986;67(1):27-30
11. Kelton JG, Warkentin TE. Diagnosis of heparin-induced thrombocytopenia: still a journey, not yet a destination. (Editorial) Am J Clin Pathol 1995;104(6):611-3
12. Warkentin TE, Hayward CP, Smith CA, et al. Determinants of donor platelet variability when testing for heparin-induced thrombocytopenia. J Lab Clin Med 1992;120(3):371-9
13. Chong BH, Burgess J, Ismail F. The clinical usefulness of the platelet aggregation test for the diagnosis of heparin-induced thrombocytopenia. Thromb Haemost 1993; 69(4):344-50
14. 14C-serotonin release assay in the diagnosis of heparin-induced thrombocytopenia. Am J Clin Pathol 1995;104(6): 648-54
15. Amiral J, Bridey F, Dreyfus M, et al. Platelet factor 4 complexed to heparin is the target for antibodies generated in heparin-induced thrombocytopenia. (Letter) Thromb Haemost 1992;68(1):95-6
16. Greinacher A, Potzsch B, Amiral J, et al. Heparin-associated thrombocytopenia: isolation of the antibody and characterization of a multimolecular PF4-heparin complex as the major antigen. Thromb Haemost 1994;71(2):247-51
17. Visentin GP, Ford SE, Scott JP, et al. Antibodies from patients with heparin-induced thrombocytopenia/thrombosis are specific for platelet factor 4 complexed with heparin or bound to endothelial cells. J Clin Invest 1994;93(1):81-8
18. Kelton JG, Smith JW, Warkentin TE, et al. Immunoglobulin G from patients with heparin-induced thrombocytopenia binds to a complex of heparin and platelet factor 4. Blood 1994;83(11):3232-9
19. Warkentin TE, Kelton JG. Heparin-induced thrombocytopenia. Annu Rev Med 1989;40:31-44
20. Kelton JG, Sheridan D, Santos A, et al. Heparin-induced thrombocytopenia: laboratory studies. Blood 1988;72(3): 925-30
21. Warkentin TE, Hayward CP, Boshkov LK, et al. Sera from patients with heparin-induced thrombocytopenia generate platelet-derived microparticles with procoagulant activity: an explanation for the thrombotic complications of heparin-induced thrombocytopenia. Blood 1994; 84(11):3691-9
22. Demers C, Ginsberg JS, Brill-Edwards P, et al. Rapid anticoagulation using ancrod for heparin-induced thrombocytopenia. Blood 1991;78(9):2194-7
23. Magnani HN. Heparin-induced thrombocytopenia (HIT): an overview of 230 patients treated with orgaran (Org 10172). Thromb Haemost 1993;70(4):554-61 [Erratum, Thromb Haemost 1993; 70(6):1072]